[NEW] Skibidi Toilet Morphs vs No More Time [ALPHA]
[NEW] Skibidi Toilet Morphs currently leads with 426 concurrent players against 335. On all-time peak the record belongs to No More Time [ALPHA] at 563 concurrent players, versus 547. Lifetime, [NEW] Skibidi Toilet Morphs has more visits (177.8M vs 18.9M). Full side-by-side history for [NEW] Skibidi Toilet Morphs and No More Time [ALPHA] is charted above.
[😱NEW] Skibidi Toilet Morphs
426
playing now
547 24h peak · 177.8M visits
VS
No More Time [ALPHA]
335
playing now
488 24h peak · 18.9M visits
Player count history
[NEW] Skibidi Toilet MorphsNo More Time [ALPHA]
Head to head
| Metric | [NEW] Skibidi Toilet Morphs | No More Time [ALPHA] | Difference |
|---|---|---|---|
| Playing now | 426 | 335 | 91 |
| 24h peak | 547 | 488 | 59 |
| 24h average | 381 | 349 | 32 |
| 7-day peak | 547 | 542 | 5 |
| 7-day average | 391 | 402 | 11 |
| 30-day peak | 547 | 542 | 5 |
| All-time peak | 547 | 563 | 16 |
| 24h change | ▼ 13.8% | ▼ 12.5% | — |
| 7d change | — | — | — |
| Total visits | 177.8M | 18.9M | 158.9M (9.4×) |
| Visits (24h) | 47.3K | 32.2K | 15.1K |
| Visits (7d) | 62.1K | 210.1K | 148K (3.4×) |
| Favorites | 60.1K | 224.3K | 164.2K (3.7×) |
| Rating | 72.9% | 88.1% | — |
| Global rank (players) | #2,007 | #2,155 | of 7,327 |
| Trending score | -6.2 | -31.7 | — |
| Created | Oct 2, 2023 | Feb 17, 2025 | — |
| Genre | Adventure | Obby & Platformer | — |
Other comparisons
[NEW] Skibidi Toilet Morphs vs Trolls can't break this tower 4[NEW] Skibidi Toilet Morphs vs obby z serniczków[NEW] Skibidi Toilet Morphs vs Anomoly Hospital [ADMIN PANEL][NEW] Skibidi Toilet Morphs vs Pippo Tower[NEW] Skibidi Toilet Morphs vs [BETA] PreCure! All Stars[NEW] Skibidi Toilet Morphs vs Friendship Test! [2-6 Player Quiz]Compare two other games →
Both games are sampled on the same schedule and plotted on a shared time axis, so the comparison is like for like. Peaks, averages and growth come from RoVitals's own recorded history — 2 days for [NEW] Skibidi Toilet Morphs, 6 for No More Time [ALPHA].